Hannah Joseph Hospital Limited promoter group member Daniel Dayanand Fenn acquired 2,000 equity shares through open market transactions on September 29, 2026. This acquisition increases his individual holding to 14,015 shares, representing 0.062% of the company's total voting capital.

The transaction was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Fenn is part of the promoter group, which includes Dr. Moses Joseph Arunkumar and other family members. The purchase was executed on the BSE, where the company's shares are listed.

Shareholding Structure Post-Acquisition

The acquisition marks a marginal increase in the promoter group's aggregate stake. While the individual holding rose by 0.009%, the total group holding moved from 71.493% to 71.502%. The table below details the shareholding changes for the acquirer and Persons Acting in Concert (PAC).

Regulatory Disclosure Details

The disclosure confirms that the acquisition was made in the open market. The total equity share capital of the target company remains unchanged at ₹22,69,83,630, divided into 2,26,98,363 equity shares of ₹10 each. There are no encumbrances, warrants, or convertible securities associated with this specific transaction or the acquirer's existing holdings.

What the Numbers Show

The data highlights a significant concentration of ownership within the promoter family. Dr. Moses Joseph Arunkumar alone holds 69.41% of the total share capital, while the entire promoter group controls over 71% of the company. The recent acquisition by Daniel Dayanand Fenn, though small in absolute terms (2,000 shares), reinforces the promoter group's dominant control, with no dilution of their aggregate stake observed in this transaction.

Daniel Dayanand Fenn acquired 2,000 equity shares of Hannah Joseph Hospital in the open market on September 18, 2026. The transaction increased his individual holding to 12,015 shares, representing 0.053% of the company’s total voting capital.

The acquisition was disclosed under Regulation 29(2) of the SEBI (Substantial Acquisition of Shares and Takeovers) Regulations, 2011. Fenn, a member of the promoter group, purchased the shares directly from the market rather than through a preferential allotment or rights issue.

Shareholding Structure

Fenn’s post-transaction holding stands at 12,015 shares. He had previously held 10,015 shares, accounting for 0.044% of the equity capital. The purchase adds 0.009% to his individual stake.

No shares were encumbered, pledged, or subject to non-disposal undertakings following the transaction. There were no warrants or convertible securities involved.

Promoter Group Holdings

Fenn acts in concert with five other individuals: Dr. Moses Joseph Arunkumar, Dr. Fenn Kavitha Fenn Arunkumar, Dr. Arunkumar Nalina, Mr. Noyel Arunkumar, and Mr. James Prabhukumar Moses. Collectively, the promoter group’s holding increased from 1,62,26,400 shares (71.484%) to 1,62,28,400 shares (71.493%).

Dr. Moses Joseph Arunkumar remains the largest shareholder within the group, holding 1,57,54,925 shares, or 69.41% of the total capital. His stake remained unchanged during this period.

What the Numbers Show

The promoter group controls over 71% of the company’s voting power, with Dr. Moses Joseph Arunkumar alone holding nearly 70% of the equity. This high concentration indicates that control rests firmly with a single individual within the promoter circle, leaving minimal free float for public trading relative to total capital.